Allied Blenders & Distillers has granted 2,25,000 stock options to eligible employees under the ABD Employee Stock Option Scheme-2024, following approval by the company's Nomination and Remuneration Committee at its meeting held on May 12, 2026. The committee meeting concluded at 7:30 P.M. (IST). The grant has been disclosed to stock exchanges pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key Details of the ESOP Grant

The stock options have been granted at a price of ₹588.45 per option, determined on the basis of the market price of the company's equity shares immediately prior to the grant date. Each option, upon exercise, entitles the holder to one equity share of Allied Blenders & Distillers with a face value of ₹2/- each. The grant is compliant with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

The table below summarises the key parameters of the ESOP grant:

Vesting Schedule

The options are structured with a purely performance-based vesting schedule, spread equally across four tranches over 48 months from the date of grant. There is no time-based vesting component under this grant. The vesting details are as follows:

Compliance and Disclosure

The intimation has been made in accordance with SEBI Master Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated January 30, 2026. The disclosure was signed by Sumeet Maheshwari, Company Secretary and Compliance Officer (Membership No. A15145), on behalf of Allied Blenders & Distillers. The company has also uploaded the intimation on its official website at www.abdindia.com . All other parameters including options exercised, options lapsed, money realised, and variation of terms are reported as not applicable at this stage.

Allied Blenders & Distillers has intimated stock exchanges of a Board of Directors meeting scheduled for Thursday, May 14, 2026, pursuant to Regulation 29 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting will take up several key agenda items, including the approval of financial results for the quarter and financial year ended March 31, 2026. Following the board meeting, the company has also scheduled a conference call on Friday, May 15, 2026, at 3:00 PM (IST), to discuss its 4QFY26 earnings with analysts, institutional investors, and other participants.

Key Agenda Items

The board meeting has been convened to consider and approve the following matters, as detailed in the company's regulatory filing:

Fund-Raising Revalidation

The board will consider the revalidation of a fund-raising approval that was originally granted at the 17th Annual General Meeting held on July 8, 2025. The approval covers raising of funds through issuance of equity shares and/or other securities, including:

• Securities convertible into equity shares
• Warrants or fully convertible debentures
• Partly convertible debentures
• Non-convertible debentures along with warrants
• Convertible preference shares

The fund-raising may be undertaken by way of public issue, rights issue, preferential allotment, private placement, including Qualified Institutions Placement(s) (QIP), in one or more tranches or any other mode or combination thereof as permitted under applicable laws. The revalidation remains subject to shareholder approval at the forthcoming AGM and such other regulatory or statutory approvals as may be required.

Q4FY26 Earnings Conference Call

Pursuant to Regulation 30(6) read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company has scheduled a conference call to discuss its 4QFY26 earnings. The call is organised in association with Antique Stock Broking Limited. Key details of the conference call are as follows:

The company has clarified that no Unpublished Price Sensitive Information is proposed to be shared during the conference call. The date and time of the call are subject to change due to exigencies on the part of investors or the company.

The senior management team participating in the conference call includes:

• Mr. Shekhar Ramamurthy – Executive Deputy Chairman
• Mr. Alok Gupta – Managing Director
• Mr. Amar Sinha – Managing Director – Designate
• Mr. Ramakrishnan Ramaswamy – Chief Financial Officer
• Mr. J. Mukund – Head of Investor Relations and Chief Risk Officer

Insider Trading Window Closure

In accordance with the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons and their Immediate Relatives, the trading window for designated persons has been closed from April 1, 2026, and will remain closed until the expiry of 48 hours after the declaration of the audited financial results for the quarter and financial year ended March 31, 2026.

Both intimations have been filed by Sumeet Maheshwari, Company Secretary and Compliance Officer (Membership No. ACS 15145), and have also been uploaded on the company's website at www.abdindia.com .